Cargando…

Stratified Platelet-to-lymphocyte Ratio: A Novel Target for Prognostic Prediction of Hepatocellular Carcinoma after Curative Liver Resection

Background and Aims: Platelet-to-lymphocyte ratio (PLR) has been shown to predict prognosis of cancers. We aimed to evaluate the prognostic value of stratification of PLR in patients after curative liver resection (CLR) for hepatocellular carcinoma (HCC). Methods: A total of 1804 patients who underw...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Gui-Qian, Zheng, Ji-Na, Zou, Tian-Tian, Chen, Yi-Ran, Shi, Ke-Qing, Poucke, Sven Van, Cheng, Zhang, Ruan, Lu-Yi, Zheng, Ming-Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: XIA & HE Publishing Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5411355/
https://www.ncbi.nlm.nih.gov/pubmed/28507925
http://dx.doi.org/10.14218/JCTH.2016.00035
_version_ 1783232815436922880
author Huang, Gui-Qian
Zheng, Ji-Na
Zou, Tian-Tian
Chen, Yi-Ran
Shi, Ke-Qing
Poucke, Sven Van
Cheng, Zhang
Ruan, Lu-Yi
Zheng, Ming-Hua
author_facet Huang, Gui-Qian
Zheng, Ji-Na
Zou, Tian-Tian
Chen, Yi-Ran
Shi, Ke-Qing
Poucke, Sven Van
Cheng, Zhang
Ruan, Lu-Yi
Zheng, Ming-Hua
author_sort Huang, Gui-Qian
collection PubMed
description Background and Aims: Platelet-to-lymphocyte ratio (PLR) has been shown to predict prognosis of cancers. We aimed to evaluate the prognostic value of stratification of PLR in patients after curative liver resection (CLR) for hepatocellular carcinoma (HCC). Methods: A total of 1804 patients who underwent CLR for suspected HCC between January 2007 and January 2014 were screened for the study. All of the patients were categorized into equal tertiles according to the number of patients and the distribution of PLR. Prognostic significance was determined for overall survival (OS) and was assessed using Kaplan–Meier analysis. Univariate and multivariate Cox proportional hazard regression analyses were evaluated for association of all independent parameters with disease prognosis. Results: The optimal cut-off points of preoperative PLR were: (T1) 11.98–75.00, (T2) 75.00–113.33 and (T3) 113.33–567.50. There were obvious differences in each PLR tertile with mortality within 36 months of CLR (p(log-rank) < 0.001). Multivariable analysis suggested that the level of PLR (HR = 1.004, 95%CI: 1.001–1.008, p = 0.006), portal vein thrombosis (HR = 3.406, 95%CI: 1.185–9.794, p = 0.023), number of nodules (HR = 1.810, 95%CI: 1.345–2.437, p < 0.001), Child-Turcotte-Pugh score (HR = 1.741, 95%CI: 1.129–2.684, p = 0.012) and microvascular invasion (HR = 2.730, 95%CI: 1.777–4.196, p < 0.001) were significant predictors of mortality. Kaplan–Meier analysis of overall survival (OS) demonstrated that each PLR tertile showed a progressively worse OS and apparent separation (p(log-rank) = 0.016). The highest 5-year OS rate following CLR (58%) was revealed in tertile 1. In contrast, the lowest 5-year OS rate (30%) was revealed in tertile 3. Conclusion: Stratified preoperative PLR could strengthen the predictive power for OS in HCC patients with CLR.
format Online
Article
Text
id pubmed-5411355
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher XIA & HE Publishing Inc.
record_format MEDLINE/PubMed
spelling pubmed-54113552017-05-15 Stratified Platelet-to-lymphocyte Ratio: A Novel Target for Prognostic Prediction of Hepatocellular Carcinoma after Curative Liver Resection Huang, Gui-Qian Zheng, Ji-Na Zou, Tian-Tian Chen, Yi-Ran Shi, Ke-Qing Poucke, Sven Van Cheng, Zhang Ruan, Lu-Yi Zheng, Ming-Hua J Clin Transl Hepatol Original Article Background and Aims: Platelet-to-lymphocyte ratio (PLR) has been shown to predict prognosis of cancers. We aimed to evaluate the prognostic value of stratification of PLR in patients after curative liver resection (CLR) for hepatocellular carcinoma (HCC). Methods: A total of 1804 patients who underwent CLR for suspected HCC between January 2007 and January 2014 were screened for the study. All of the patients were categorized into equal tertiles according to the number of patients and the distribution of PLR. Prognostic significance was determined for overall survival (OS) and was assessed using Kaplan–Meier analysis. Univariate and multivariate Cox proportional hazard regression analyses were evaluated for association of all independent parameters with disease prognosis. Results: The optimal cut-off points of preoperative PLR were: (T1) 11.98–75.00, (T2) 75.00–113.33 and (T3) 113.33–567.50. There were obvious differences in each PLR tertile with mortality within 36 months of CLR (p(log-rank) < 0.001). Multivariable analysis suggested that the level of PLR (HR = 1.004, 95%CI: 1.001–1.008, p = 0.006), portal vein thrombosis (HR = 3.406, 95%CI: 1.185–9.794, p = 0.023), number of nodules (HR = 1.810, 95%CI: 1.345–2.437, p < 0.001), Child-Turcotte-Pugh score (HR = 1.741, 95%CI: 1.129–2.684, p = 0.012) and microvascular invasion (HR = 2.730, 95%CI: 1.777–4.196, p < 0.001) were significant predictors of mortality. Kaplan–Meier analysis of overall survival (OS) demonstrated that each PLR tertile showed a progressively worse OS and apparent separation (p(log-rank) = 0.016). The highest 5-year OS rate following CLR (58%) was revealed in tertile 1. In contrast, the lowest 5-year OS rate (30%) was revealed in tertile 3. Conclusion: Stratified preoperative PLR could strengthen the predictive power for OS in HCC patients with CLR. XIA & HE Publishing Inc. 2017-02-25 2017-03-28 /pmc/articles/PMC5411355/ /pubmed/28507925 http://dx.doi.org/10.14218/JCTH.2016.00035 Text en © 2017 Authors. http://creativecommons.org/licenses/by-nc/4.0/ This article has been published under the terms of Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0), which permits noncommercial unrestricted use, distribution, and reproduction in any medium, provided that the following statement is provided. “This article has been published in Journal of Clinical and Translational Hepatology at DOI: 10.14218/JCTH.2016.00035 and can also be viewed on the Journal’s website at http://www.jcthnet.com”.
spellingShingle Original Article
Huang, Gui-Qian
Zheng, Ji-Na
Zou, Tian-Tian
Chen, Yi-Ran
Shi, Ke-Qing
Poucke, Sven Van
Cheng, Zhang
Ruan, Lu-Yi
Zheng, Ming-Hua
Stratified Platelet-to-lymphocyte Ratio: A Novel Target for Prognostic Prediction of Hepatocellular Carcinoma after Curative Liver Resection
title Stratified Platelet-to-lymphocyte Ratio: A Novel Target for Prognostic Prediction of Hepatocellular Carcinoma after Curative Liver Resection
title_full Stratified Platelet-to-lymphocyte Ratio: A Novel Target for Prognostic Prediction of Hepatocellular Carcinoma after Curative Liver Resection
title_fullStr Stratified Platelet-to-lymphocyte Ratio: A Novel Target for Prognostic Prediction of Hepatocellular Carcinoma after Curative Liver Resection
title_full_unstemmed Stratified Platelet-to-lymphocyte Ratio: A Novel Target for Prognostic Prediction of Hepatocellular Carcinoma after Curative Liver Resection
title_short Stratified Platelet-to-lymphocyte Ratio: A Novel Target for Prognostic Prediction of Hepatocellular Carcinoma after Curative Liver Resection
title_sort stratified platelet-to-lymphocyte ratio: a novel target for prognostic prediction of hepatocellular carcinoma after curative liver resection
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5411355/
https://www.ncbi.nlm.nih.gov/pubmed/28507925
http://dx.doi.org/10.14218/JCTH.2016.00035
work_keys_str_mv AT huangguiqian stratifiedplatelettolymphocyteratioanoveltargetforprognosticpredictionofhepatocellularcarcinomaaftercurativeliverresection
AT zhengjina stratifiedplatelettolymphocyteratioanoveltargetforprognosticpredictionofhepatocellularcarcinomaaftercurativeliverresection
AT zoutiantian stratifiedplatelettolymphocyteratioanoveltargetforprognosticpredictionofhepatocellularcarcinomaaftercurativeliverresection
AT chenyiran stratifiedplatelettolymphocyteratioanoveltargetforprognosticpredictionofhepatocellularcarcinomaaftercurativeliverresection
AT shikeqing stratifiedplatelettolymphocyteratioanoveltargetforprognosticpredictionofhepatocellularcarcinomaaftercurativeliverresection
AT pouckesvenvan stratifiedplatelettolymphocyteratioanoveltargetforprognosticpredictionofhepatocellularcarcinomaaftercurativeliverresection
AT chengzhang stratifiedplatelettolymphocyteratioanoveltargetforprognosticpredictionofhepatocellularcarcinomaaftercurativeliverresection
AT ruanluyi stratifiedplatelettolymphocyteratioanoveltargetforprognosticpredictionofhepatocellularcarcinomaaftercurativeliverresection
AT zhengminghua stratifiedplatelettolymphocyteratioanoveltargetforprognosticpredictionofhepatocellularcarcinomaaftercurativeliverresection